Effects of estradiol-drospirenone on ocular and nasal functions in postmenopausal women

ÇOKSUER H., ÖZCURA F., OĞHAN F., Haliloglu B., ÇOKSUER C.

CLIMACTERIC, vol.14, no.4, pp.482-487, 2011 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 14 Issue: 4
  • Publication Date: 2011
  • Doi Number: 10.3109/13697137.2010.539724
  • Journal Name: CLIMACTERIC
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.482-487
  • Keywords: HORMONE REPLACEMENT THERAPY, DROSPIRENONE, ANGELIQ, DRY EYE, OCULAR DISEASE, NASAL AIRFLOW, HORMONE REPLACEMENT THERAPY, DRY EYE, LENS OPACITIES, RHINOMANOMETRIC OUTCOMES, REPRODUCTIVE FACTORS, MG DROSPIRENONE, TEAR FUNCTION, ESTROGEN, MENOPAUSE, AGE
  • Kütahya Health Sciences University Affiliated: No

Abstract

Background Hormones may have an impact on the incidence and course of dry-eye syndrome, and also nasal obstruction, especially in postmenopausal women. The aim of this study was to investigate the effects of drospirenone 2 mg + estradiol 1 mg (Angeliq (R), Bayer AG, Berlin, Germany) on ocular functions and nasal airflow in postmenopausal women.